Simpson Sissons & Brooke Solicitors

Asbestos related lung cancer is a prescribed disease providing the patient shows another clinical sign of asbestos exposure, such as asbestosis or pleural thickening. Evidence would also have to be provided of occupational asbestos exposure.

The number of lung cancer cases currently attributed to asbestos exposure in the UK may be estimated at around 1800 per year.

The latency period for lung cancer associated with asbestos exposure is usually between fifteen and 35 years.